During the past decade, UCLA Center for Inflammatory Bowel Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Center for Inflammatory Bowel Diseases" #1 collaborator was "Genova Diagnostics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Center for Inflammatory Bowel Diseases" are "Celiac Disease" (1 trials), "Cirrhosis" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "UCLA Center for Inflammatory Bowel Diseases" in a lesser frequency.

Most popular intervention types in "UCLA Center for Inflammatory Bowel Diseases" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hematopoietic stem cell transplantation" (1 trials) and "Vivify Kit" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Center for Inflammatory Bowel Diseases" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Center for Inflammatory Bowel Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCLA Center for Inflammatory Bowel Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Center for Inflammatory Bowel Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".